Magnesium decreased 200 CNY/T or 1.18% since the beginning of 2025, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity. This dataset includes a chart with historical data for Magnesium.

Magnesium chloride prices in the USA plummeted to 575 USD/MT in Q4 2023, owing to feeble demand from industries like textiles and water treatment, a supply-demand imbalance, and poor winter operation rates. Energy costs also contributed to the declining trend. The market encountered issues due to falling prices and oversupply, which were caused by weak demand and seasonal considerations.

Magnesium Chloride Prices December 2023

Explore IMARC’s newly published report, titled “Magnesium Chloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of magnesium chloride pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

This is a peer-reviewed supplementary table for the article 'Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data' published in the Journal of Comparative Effectiveness Research.Supplementary Table 1: MG treatment definitionsAim: There are limited data on the clinical and economic burden of exacerbations in patients with myasthenia gravis (MG). We assessed patient clinical characteristics, treatments and healthcare resource utilization (HCRU) associated with MG exacerbation. Patients & methods: This was a retrospective analysis of adult patients with MG identified by commercial, Medicare or Medicaid insurance claims from the IBM MarketScan database. Eligible patients had two or more MG diagnosis codes, without evidence of exacerbation or crisis in the baseline period (12 months prior to index [first eligible MG diagnosis]). Clinical characteristics were evaluated at baseline and 12 weeks before each exacerbation. Number of exacerbations, MG treatments and HCRU costs associated with exacerbation were described during a 2-year follow-up period. Results: Among 9352 prevalent MG patients, 34.4% (n = 3218) experienced ≥1 exacerbation after index: commercial, 53.0% (n = 1706); Medicare, 39.4% (n = 1269); and Medicaid, 7.6% (n = 243). During follow-up, the mean (standard deviation) number of exacerbations per commercial and Medicare patient was 3.7 (7.0) and 2.7 (4.1), respectively. At least two exacerbations were experienced by approximately half of commercial and Medicare patients with ≥1 exacerbation. Mean total MGrelated healthcare costs per exacerbation ranged from $26,078 to $51,120, and from $19,903 to $49,967 for commercial and Medicare patients, respectively. AChEI use decreased in patients with multiple exacerbations, while intravenous immunoglobulin use increased with multiple exacerbations. Conclusion: Despite utilization of current treatments for MG,MG exacerbations are associated with a high clinical and economic burden in both commercial and Medicare patients. Additional treatment options and improved disease management may help to reduce exacerbations and disease burden.

The magnesium stearate prices in the USA for Q2 2023 reached 970 USD/MT in June. The market prices started weak in Q2 2023 due to reduced need and lower upstream costs. Trade tensions with China increased market hesitancy, raising consumer prices and dampening activity. However, by late June, a rise in local or domestic inquiries, particularly in the food and pharmaceutical industries, supported a modest recovery in prices.

Magnesium Stearate Prices June 2023

Explore IMARC’s newly published report, titled “Magnesium Stearate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of magnesium stearate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.